Most Recent
Smile Direct Club bites back in lawsuit over teeth straightener claims
The maker of the popular Invisalign dental aligners may soon face a cross-claim from competitor SmileDirectClub, which it sued for allegedly misleading consumers about the cost and efficacy of its direct-to-consumer teeth alignment kits. 
IAG investigates underwriter accused of issuing unauthorised Greensill policy
Insurance Australia Group is investigating the underwriter behind an allegedly unauthorised trade credit policy issued to Greensill Capital, according to a defence by the insurer in a $43 million case brought by a Credit Suisse supply chain fund left heavily exposed after Greensill's collapse.
Settlement reached in class action against trustee of collapsed IPO Wealth
The trustee of Mayfair Group's collapsed IPO Wealth Fund has reached an in-principle settlement in a class action alleging it misled investors, who lost $86 million when the fund was wound up.
Judge signs off on $1.5M penalty against Westpac for unsolicited insurance
A judge has hit Westpac with a $1.5 million penalty for misleading 141 customers into believing they had purchased add-on insurance.
Russells wins security in $1.5M negligence suit by Macarthur Minerals shareholder
Law firm Russells has won a bid for further security against former clients in a negligence case over its handling of a shareholder suit against iron ore miner Macarthur Minerals.
‘Cranky’ judge slams ‘nonsense’ quibbling in cavoodle defamation case
A judge has barked at lawyers for Nine and a barrister who sued the media company for defamation over its coverage of her battle for custody of famed social media pooch Oscar the cavoodle, saying their “nonsense” quibbling was making him “cranky”.
Toyota could owe $2B in class action after judge finds cars were defective
Toyota could owe close to $2 billion in compensation to 260,000 car owners after a judge found that diesel filters installed in its Hilux, Fortuner and Prado models were defective and that the cars were sold for more than they were worth.
Nurofen maker Reckitt-Benckiser loses High Court appeal bid in Maxigesic feud
The High Court has rejected a special leave application by consumer goods giant Reckitt-Benckiser in its long-running battle with the maker of painkiller Maxigesic.
Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.
Court to probe if 7-Eleven class action funder, law firm had deferred fee arrangement
A marathon hearing of an application for court approval of a $98 million settlement in two 7-Eleven class actions has ended with a judge taking the rare step of signing off on the settlement amount while withholding approval of the legal costs and funding commission.